<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD006386-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD006386-sec-0008"></div> <div class="table" id="CD006386-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 1.</span> <span class="table-title">Induction chemotherapy plus locoregional treatment compared to locoregional treatment alone for the treatment of oral cavity and oropharyngeal cancer: chemotherapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Induction chemotherapy plus locoregional treatment compared to locoregional treatment alone for the treatment of oral cavity and oropharyngeal cancer: chemotherapy</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> people receiving treatment for oral cavity and oropharyngeal cancer<br><b>Setting:</b> curative intent treatment<br><b>Intervention:</b> induction chemotherapy plus locoregional treatment<br><b>Comparison:</b> locoregional treatment alone </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>№ of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="table-header separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Risk of death with locoregional treatment alone</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Risk of death with induction chemotherapy plus locoregional treatment</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>Overall survival ‐ platinum + 5‐FU + RT vs. RT</p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Low</p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>HR 0.85<br>(0.70 to 1.04) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>7427<br>(5 RCTs) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br>MODERATE <sup>1</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>173 per 1000<br>(145 to 207) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Moderate</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>500 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>445 per 1000<br>(384 to 514) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>High</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>700 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>641 per 1000<br>(569 to 714) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>Overall survival ‐ platinum + 5‐FU + surgery vs. surgery</p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Low</p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>HR 1.06<br>(0.71 to 1.60) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>198<br>(1 RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>⊕⊕⊝⊝</p> <p> LOW <sup>2</sup></p> <p> </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>211 per 1000<br>(147 to 300) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Moderate</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>500 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>520 per 1000<br>(389 to 670) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>High</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>700 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>721 per 1000<br>(575 to 854) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>Overall survival ‐ cisplatin + 5‐FU + docetaxel + CRT (cisplatin) vs. CRT (cisplatin)</p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Low</p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>HR 1.08<br>(0.80 to 1.44) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>760<br>(3 RCTs) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br>LOW <sup>3,4</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>214 per 1000<br>(163 to 275) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Moderate</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>500 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>527 per 1000<br>(426 to 631) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>High</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>700 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>728 per 1000<br>(618 to 823) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>Overall survival ‐ cisplatin + 5‐FU + CRT (cisplatin) vs. CRT (cisplatin)</p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Low</p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>HR 0.71<br>(0.37 to 1.35) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>389<br>(2 RCTs) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br>LOW <sup>3,4</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>147 per 1000<br>(79 to 275) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Moderate</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>500 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>389 per 1000<br>(226 to 631) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>High</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>700 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>575 per 1000<br>(359 to 823) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI); assumed risk based on 5‐year survival data (<a href="./references#CD006386-bbs2-0408">McGurk 2005</a>).<br><b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio; <b>Platinum:</b> either cisplatin or carboplatin </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded once due to heterogeneity in patient characteristics in the included trials </p> <p><sup>2</sup> Downgraded twice due to imprecision in effect </p> <p><sup>3</sup> Downgraded once due to imprecision in effect </p> <p><sup>4</sup> Downgraded once due to inconsistency in results </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006386-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span> <span class="table-title">Surgery + adjuvant treatment A compared to surgery + adjuvant treatment B for the treatment of oral cavity and oropharyngeal cancer: chemotherapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Surgery + adjuvant treatment A compared to surgery + adjuvant treatment B for the treatment of oral cavity and oropharyngeal cancer: chemotherapy</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> people receiving treatment for oral cavity and oropharyngeal cancer<br><b>Setting:</b> curative intent treatment<br><b>Intervention:</b> surgery + adjuvant treatment A<br><b>Comparison:</b> surgery +/‐ adjuvant treatment B </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>№ of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="table-header separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Risk of death with surgery + adjuvant treatment B</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Risk of death with surgery + adjuvant treatment A</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>Overall survival ‐ adjuvant chemotherapy vs. observation alone</p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Low</p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>HR 0.95<br>(0.73 to 1.22) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>353<br>(5 RCTs) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br>MODERATE <sup>1</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>191 per 1000<br>(150 to 238) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Moderate</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>500 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>482 per 1000<br>(397 to 571) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>High</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>700 per 1,000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>681 per 1,000<br>(585 to 770) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>Overall survival ‐ adjuvant CRT vs. adjuvant RT</p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Low</p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>HR 0.84<br>(0.72 to 0.98) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>1097<br>(4 RCTs) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br>MODERATE <sup>2</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>171 per 1000<br>(148 to 196) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Moderate</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>500 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>441 per 1000<br>(393 to 493) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>High</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>700 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>636 per 1000<br>(580 to 693) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI); assumed risk based on 5‐year survival data (<a href="./references#CD006386-bbs2-0408">McGurk 2005</a>).<br><b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded once due to imprecision in effect estimate </p> <p><sup>2</sup> Downgraded once due to heterogeneity of uncertain significance in patient characteristics in one of the included trials </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006386-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span> <span class="table-title">Concomitant chemoradiotherapy compared to radiotherapy alone (non‐resectable) for the treatment of oral cavity and oropharyngeal cancer: chemotherapy</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Concomitant chemoradiotherapy compared to radiotherapy alone (non‐resectable) for the treatment of oral cavity and oropharyngeal cancer: chemotherapy</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> people receiving treatment for oral cavity and oropharyngeal cancer<br><b>Setting:</b> curative intent treatment<br><b>Intervention:</b> concomitant chemoradiotherapy<br><b>Comparison:</b> radiotherapy alone (non‐resectable) </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>№ of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="table-header separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Risk of death with radiotherapy alone (non‐resectable)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Risk of death with concomitant chemoradiotherapy</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>Overall survival ‐ CRT vs. RT</p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Low</p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>HR 0.74<br>(0.67 to 0.83) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>2852<br>(24 RCTs) </p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p>⊕⊕⊕⊝</p> <p>MODERATE <sup>1</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="6" bgcolor="#ffffff"> <p> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>200 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>156 per 1000<br>(143 to 169) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>Moderate</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>500 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>410 per 1000<br>(380 to 437) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>High</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>700 per 1000</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>599 per 1000<br>(564 to 632) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI); assumed risk based on 5‐year survival data (<a href="./references#CD006386-bbs2-0408">McGurk 2005</a>).<br><b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>OR:</b> odds ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded once due to considerable heterogeneity among included trials </p> <p>(radiation therapy scheduled varied across included studies)</p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
